HSTM.NASDAQHealthstream INC

Form 4: HealthStream CEO Robert Frist Jr. Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Robert Frist Jr., CEO and Chairman of HealthStream Inc., reports the acquisition and disposal of company stock and restricted share units on September 27, 2024.

Summary

  • Robert A. Frist Jr., CEO and Chairman of HealthStream Inc. (HSTM), filed a Form 4 detailing changes in beneficial ownership.
  • On September 27, 2024, Frist acquired 527 shares of common stock upon vesting of restricted share units (RSUs).
  • Also on September 27, 2024, 129 shares were disposed of to cover tax liabilities at a price of $28.31 per share.
  • Following these transactions, Frist directly owns 4,752,087 shares of HealthStream Inc.
  • Frist also indirectly owns shares through various trusts, including The Carolyn Marie Frist 2005 Vested Trust, The Cate Merriman Frist 2005 Vested Trust, The Eleanor Knox Frist 2005 Vested Trust, Louise Trust u/a/d 08-16-2007, Merriman Trust u/a/d 08-16-2007, Marie Trust u/a/d 08-16-2007, Knox Trust u/a/d 08-16-2007 and Bobby and Melissa Frist Children's 2012 GST-Exempt Trust.
  • Frist directly owns 2,988 Restricted Share Units.
  • The RSUs vest over four years, contingent upon continued service, with vesting dates in September 2024, 2025, 2026, and 2027.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The filing reflects routine transactions related to executive compensation. The disposal of shares for tax purposes is a common occurrence and doesn't necessarily indicate a negative outlook.

Positives

  • The vesting of restricted share units suggests continued alignment of the CEO's interests with the company's performance.

Negatives

  • The disposal of shares to cover tax liabilities, while common, could be perceived negatively if investors interpret it as a lack of confidence, although the amount is small relative to his total holdings.

Risks

  • There are no immediate risks apparent from this filing.
  • However, continued disposal of shares, even for tax purposes, could create negative sentiment if it becomes a recurring pattern.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and major shareholders. These filings are closely watched by investors for signals about management's confidence in the company's prospects.

Comparison to Industry Standards

  • Monitoring insider transactions is a standard practice in corporate governance.
  • Comparing Frist's transactions to those of executives at similar healthcare technology companies (e.g., Cerner, Allscripts) can provide context.
  • The vesting schedule of the RSUs is typical for executive compensation packages.

Stakeholder Impact

  • The transactions have a minimal direct impact on stakeholders.
  • However, transparency in insider transactions is important for maintaining investor confidence.

Key Dates

DateDescription
08-16-2007Date of trust u/a/d for Louise, Merriman, Marie and Knox Trusts
09/20/202415% of RSUs vest
09/27/2024Date of stock acquisition and disposal.
09/20/202520% of RSUs vest
09/20/202630% of RSUs vest
09/20/202735% of RSUs vest
10/01/2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.